
    
      The study is a single-center study with a cross-over design to examine glycemia, incretin
      hormones and islet hormones over a 24h study period with standardized breakfast, lunch and
      dinner after administration of placebo, saxagliptin, vildagliptin or sitagliptin.
    
  